Granite Harbor Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$515K Buy
21,404
+2,024
+10% +$52.9K 0.2% 80
2026
Q1
$544K Buy
19,380
+2,092
+12% +$55.7K 0.24% 74
2025
Q4
$430K Buy
17,288
+1,816
+12% +$45.8K 0.18% 80
2025
Q3
$394K Buy
15,472
+1,724
+13% +$42.6K 0.17% 90
2025
Q2
$333K Buy
13,748
+4,020
+41% +$93.8K 0.16% 87
2025
Q1
$247K Buy
+9,728
New +$255K 0.13% 89
2024
Q4
Sell
-7,236
Closed -$209K 90
2024
Q3
$209K Buy
+7,236
New +$211K 0.12% 89

Other funds holding PFE

Granite Harbor Advisors's PFE Position: Q2 2026 in Review

Granite Harbor Advisors increased its Pfizer (PFE) stake by 10% in Q2 2026, buying an estimated $52.9K and bringing the position to 21,404 shares worth $515K. The position accounts for 0.2% of the portfolio, ranked #80.

Granite Harbor Advisors first reported a position in PFE in Q3 2024 and has held it in 7 quarters since. The position peaked at $544K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Granite Harbor Advisors held 21,404 shares of Pfizer worth $515K as of Q2 2026.
  • Granite Harbor Advisors bought 2,024 Pfizer shares in Q2 2026, an estimated $52.9K.
  • Pfizer made up 0.2% of Granite Harbor Advisors's portfolio in Q2 2026, its #80 holding.
  • Granite Harbor Advisors first reported a position in Pfizer in Q3 2024 and has held it in 7 quarters since.
  • Granite Harbor Advisors's Pfizer position peaked at $544K in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Granite Harbor Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.